REFRACTORY HODGKIN LYMPHOMA

Clinical trials for REFRACTORY HODGKIN LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new REFRACTORY HODGKIN LYMPHOMA trials appear

Sign up with your email to follow new studies for REFRACTORY HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet recruiting 1 Not yet finished but already full! 3 Completed 3

Blood test guides fight against stubborn lymphoma

Disease control Not yet recruiting

This study is testing a combination of four drugs (pembrolizumab, gemcitabine, vinorelbine, and liposomal doxorubicin) for adults whose classic Hodgkin lymphoma has returned or not responded to initial treatment. It aims to see if this treatment can achieve a deep remission, meas…

Matched conditions: REFRACTORY HODGKIN LYMPHOMA

Phase: PHASE2 • Sponsor: Michael Spinner, MD • Aim: Disease control

Last updated Mar 19, 2026 14:55 UTC

REFRACTORY HODGKIN LYMPHOMA

Get alerted when new REFRACTORY HODGKIN LYMPHOMA trials appear

Blood test guides fight against stubborn lymphoma